Tong-Hsuan Chang

Title: Innovations of Tong-Hsuan Chang in Therapeutic Antibodies

Introduction

Tong-Hsuan Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of therapeutic antibodies, with a focus on targeting specific antigens expressed in various cancers. With a total of 5 patents to his name, Chang's work is paving the way for advancements in cancer treatment and detection.

Latest Patents

Chang's latest patents involve the development of humanized antibodies, antigen-binding fragments, and antibody conjugates. These innovations are designed to specifically bind to biantennary Lewis antigens, which are expressed in a variety of cancers. The disclosed antibodies are instrumental in targeting antigen-expressing cells for the treatment or detection of diseases, including various forms of cancer. Additionally, the patents provide polynucleotides, vectors, and host cells for producing these antibodies and their fragments. Pharmaceutical compositions, methods of treatment and detection, and various uses of the antibodies and compositions are also included in his patents.

Career Highlights

Tong-Hsuan Chang is currently associated with Glyconex, Inc., where he continues to advance his research in therapeutic antibodies. His work is characterized by a commitment to innovation and a focus on improving cancer treatment methodologies.

Collaborations

Chang collaborates with notable colleagues, including Jerry Ting and Shu-Yen Chang, to further enhance the impact of his research in the field of therapeutic antibodies.

Conclusion

Tong-Hsuan Chang's contributions to the field of therapeutic antibodies represent a significant advancement in cancer treatment and detection. His innovative work continues to inspire and drive progress in medical research.